TrialBMC medicine2024

Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China.

Yanhua Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.